Correction to: A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99m Tc-TRODAT-1 SPECT to
- PDF / 343,599 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 57 Downloads / 173 Views
CORRECTION
Correction to: A phase 2, open‑label, multi‑center study to evaluate the efficacy and safety of 99mTc‑TRODAT‑1 SPECT to detect Parkinson’s disease Yu Sun1 · Congjin Liu1 · Zhengping Chen2 · Biao Li3 · Zhongwei Lv4 · Jingjing Lou5 · Jie Tang2 · Yuankai Wang1 · Guangming Zhang1 · Xingdang Liu1
© The Japanese Society of Nuclear Medicine 2020
Correction to: Annals of Nuclear Medicine https://doi.org/10.1007/s12149-019-01412-2
The corresponding author of the article would like to remove “Jian Wang” in the author group. The revised author group is given in this correction. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article can be found online at https://doi.org/10.1007/ s12149-019-01412-2. * Jingjing Lou [email protected] * Xingdang Liu [email protected] 1
Department of Nuclear Medicine, Huashan Hospital, Fudan University, No. 12 Wulumuqi Middle Road, Jing’an District, Shanghai 200040, China
Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, No. 20 Qianrong Road, Binhu District, Wuxi 214063, Jiangsu, China
2
3
Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, No. 197, Ruijin Er Road, Shanghai 200025, China
4
Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, 301 Yangchang Middle Road, Jing’an District, Shanghai 200072, China
5
Universal Medical Imaging Diagnostic Center, No. 406 Guilin Road, Xuhui District, Shanghai 200233, China
13
Vol.:(0123456789)
Data Loading...
